In this regard, a recent meta-analysis showed that thyroid hormone treatment was effective in patients with heart failure suffering from NTIS (22).Therefore, future studies are justified to explore the clinical value of thyroid hormone therapy or, possibly, therapy with liver-specific TRβ-agonists in order to harvest beneficial hepatic effects while avoiding adverse extrahepatic effects in AD and ACLF. Here, THRB is linked to heart failure.